Navigation Links
Valentine's Day Provides Families with Teachable Moments About Potentially Life-Threatening Allergies
Date:1/31/2013

n needs than a shy one. Help them grow to become their own advocate by starting where they are right now.
  • Recognize that while having an anaphylaxis action plan is critical, open dialogue about the plan and how it applies to different situations is a key element of being aware and prepared.
  • Discuss the anaphylaxis action plan with specific emphasis on the need to avoid allergic triggers and to always have EpiPen Auto-Injectors on hand in case anaphylaxis occurs.
  • Communicate that there should not be a fear of using the EpiPen Auto-Injector immediately during a life-threatening allergic reaction. In fact, delays in epinephrine administration have been associated with negative health consequences, even possibly death. Since there are no absolute contraindications to epinephrine administration for an anaphylactic reaction, it is important to administer epinephrine immediately even if all criteria for anaphylaxis diagnosis have not yet been met. Remember, EpiPen Auto-Injector is not a substitute for emergency medical treatment. Seek immediate medical care after EpiPen Auto-Injector is administered.
  • Remember to check in with your allergist or other health care provider to discuss any concerns you may have about cross contamination and to review/update your anaphylaxis action plan.

    • For more information on anaphylaxis, life-threatening allergies and EpiPen Auto-Injector, visit http://epipen.mediaroom.com/.  

    About Anaphylaxis

    Anaphylaxis is a life-threatening allergic reaction that has many possible triggers, occurs quickly, without warning, and must be treated immediately with epinephrine. Symptoms may include hives or redness of the skin, tightness in the throat, nausea, dizziness, breathing problems, a decrease in blood pressure and/or fainting. Anaphylaxis can be caused by triggers such as food, stinging and biting insects, medicines, latex or even exercis
    '/>"/>

    SOURCE Mylan Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
    2. Cadence Pharmaceuticals Estimates Fourth Quarter 2012 Net Product Revenue and Provides Full Year 2013 Revenue Guidance
    3. CVS Caremark Provides Strong Growth Outlook for 2013 and Beyond, Announces 38%Dividend Increase and Outlines Strategic Growth Framework
    4. Lilly Provides Update on Next Steps for Solanezumab
    5. Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
    6. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
    7. Computer-navigated total knee replacement provides no advantage over traditional surgical procedure
    8. Trovagene, Inc., Announces Third Quarter and Year to Date Earnings, Provides Milestone Update
    9. Ampio Provides Progress Report on Clinical Programs in Preparation for Annual Shareholders Meeting
    10. Cannabis Science Provides Corporate Guidance on Preclinical Initiatives and Recent Corporate Developments for its Shareholders; CBIS Announces plans for 1st Q of 2013 Webinar Investor Call
    11. BioDelivery Sciences Provides Business Update and Summary of Third Quarter Results of Operations
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2013)... May 22, 2013 /PRNewswire-iReach/ -- MarketReportsOnline.com announces addition ... Guidebook Series (4) 2013 Edition Material and Clinical ... Drug Registration: A Guidebook of Registration Application for ... to its online database. The traditional ... are always regarded by occidental as mysterious medicines. ...
    (Date:5/22/2013)... VANCOUVER, British Columbia , May 22, 2013  OncoGenex ... the development of novel therapeutics to target mechanisms of treatment ... investigational compounds, custirsen and OGX-427, will be presented as "Trials ... of the American Society of Clinical Oncology (ASCO) in ... 4. Despite the availability of drugs that ...
    (Date:5/21/2013)... 2013 Concord Medical Services Holdings Limited ("Concord ... a leading specialty hospital management solution provider and operator ... centers in China and the parent of Chang,an Hospital, ... first quarter ended March 31, 2013 [1] . ... revenue, which consists of net revenues generated from the ...
    Breaking Medicine Technology:China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 2OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 3OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 4OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 5Concord Medical Reports First Quarter 2013 Financial Results 2Concord Medical Reports First Quarter 2013 Financial Results 3Concord Medical Reports First Quarter 2013 Financial Results 4Concord Medical Reports First Quarter 2013 Financial Results 5Concord Medical Reports First Quarter 2013 Financial Results 6Concord Medical Reports First Quarter 2013 Financial Results 7Concord Medical Reports First Quarter 2013 Financial Results 8Concord Medical Reports First Quarter 2013 Financial Results 9Concord Medical Reports First Quarter 2013 Financial Results 10Concord Medical Reports First Quarter 2013 Financial Results 11Concord Medical Reports First Quarter 2013 Financial Results 12Concord Medical Reports First Quarter 2013 Financial Results 13
    ... 28, 2011 Pharmasset, Inc. (Nasdaq: VRUS ) ... Conference being held May 2 to 4, 2011 at the ... Merrill Lynch Healthcare Conference being held May 10 to 12, ... Price, Pharmasset,s President and Chief Executive Officer, will provide an ...
    ... 28, 2011 The U.S. Food and Drug ... with prednisone (a steroid) to treat patients with ... prior docetaxel (chemotherapy). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... sex hormone testosterone stimulates prostate tumors to grow. ...
    Cached Medicine Technology:Pharmasset to Present at Two Upcoming Investor Conferences 2Pharmasset to Present at Two Upcoming Investor Conferences 3FDA Approves Zytiga for Late-Stage Prostate Cancer 2FDA Approves Zytiga for Late-Stage Prostate Cancer 3
    (Date:5/22/2013)... 21 May 2013, Paris, France: Results from ... 2013 today question whether bivalirudin is superior ... blockade, showing similar 30-day mortality in patients ... (NSTE-ACS) undergoing percutaneous coronary intervention (PCI)., European ... alone as an alternative to unfractionated heparin ...
    (Date:5/22/2013)... 2013 In the past decade, ... and courts with donated uniforms, shoes, balls and ... dedicated to partnering with manufacturers to provide youth with ... of $8.8 million in sports and fitness equipment over ... kids outfitted for physical activity. , An inaugural ...
    (Date:5/22/2013)... Following the success of last year’s 1,000 ... Body Boot Camp Kincardine has announced it will be ... on June 3rd at its Kincardine fitness center ... Ontario.     , Fit Body Boot Camp’s 1,000 lb. Meltdown ... residents to lose a total of 1,000 pounds in ...
    (Date:5/22/2013)... NJ (PRWEB) May 22, 2013 ... and management solutions for social enterprise collaboration platforms, ... a consulting firm based in Chicago, Ill. The ... their products and provide best-in-class solutions for SharePoint ... improve collaboration. , AvePoint’s DocAve Software Platform ...
    (Date:5/22/2013)... 2013 Poor adherence to appropriate medication ... medical complications and death (some 125,000 deaths in the ... increased health-care costs. It’s been estimated that between 33% ... to poor medication adherence — a reality that costs ... Indeed, so dire is the degree of medication non-adherence ...
    Breaking Medicine News(10 mins):Health News:Registry questions superiority of bivalirudin over heparin 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 3Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2
    ... ... the latest technologies in Refractive and Corneal Surgery. , ... (Vocus) March 30, 2010 -- The Khanna Institute opens new office ... cities in the world. The city is known for its famous zip code, phenomenal shopping ...
    ... for this common condition, researchers say , TUESDAY, March 30 ... known as deep vein thrombosis, it is most likely to ... leg, Canadian researchers have found. , Dr. Wee-Shian Chan ... newly published review, said in a news release that the ...
    ... Aspirin, ibuprofen and other non-steroidal anti-inflammatory drugs ... symptoms of arthritis and other inflammatory disorders. But ... have osteoarthritis) these medications are also known to ... body, particularly in the gastrointestinal tract. ...
    ... that point to spectrum disorders , TUESDAY, March 30 ... brain proteins that seem to be linked to autism ... the most comprehensive genetic analyses of association between these ... disorder] risk," said Anthony Monaco, of the Wellcome Trust ...
    ... dying rose among older people cared for in minority ... many supportive relatives actually increases the fear of dying ... researchers. , The finding runs counter to the common ... the fear of death. It also has important implications ...
    ... has been thought that the loss of physical and psychological ... in brain structures. However, in the current edition of ... 107[12]: 199-205), Rainer Scheid and D. Yves von Cramon conclude ... brain injury is more frequent than stroke and is mostly ...
    Cached Medicine News:Health News:The Khanna Institute of LASIK and Refractive Surgery Opens New Office in Beverly Hills 2Health News:McMaster researcher leads development of promising drug for inflammation 2Health News:More Family Support Can Raise Fears For Some Elderly 2
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: